158 related articles for article (PubMed ID: 10708405)
1. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS.
Costa CG; Guérand WS; Struys EA; Holwerda U; ten Brink HJ; Tavares de Almeida I; Duran M; Jakobs C
J Pharm Biomed Anal; 2000 Jan; 21(6):1215-24. PubMed ID: 10708405
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias.
Bonafé L; Troxler H; Kuster T; Heizmann CW; Chamoles NA; Burlina AB; Blau N
Mol Genet Metab; 2000 Apr; 69(4):302-11. PubMed ID: 10870848
[TBL] [Abstract][Full Text] [Related]
3. Screening for fatty acid beta oxidation disorders. Acylglycine analysis by electron impact ionization gas chromatography-mass spectrometry.
Kimura M; Yamaguchi S
J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):105-10. PubMed ID: 10491995
[TBL] [Abstract][Full Text] [Related]
4. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
[TBL] [Abstract][Full Text] [Related]
5. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
[TBL] [Abstract][Full Text] [Related]
6. Quantitative liquid chromatography coupled with tandem mass spectrometry analysis of urinary acylglycines: application to the diagnosis of inborn errors of metabolism.
Ombrone D; Salvatore F; Ruoppolo M
Anal Biochem; 2011 Oct; 417(1):122-8. PubMed ID: 21704015
[TBL] [Abstract][Full Text] [Related]
7. Problems in the detection of fatty acid oxidation defects: experience of a quality assurance programme for qualitative urinary organic acid analysis.
Downing M; Allen JC; Bonham JR; Edwards RG; Manning NJ; Olpin SE; Pollitt RJ
J Inherit Metab Dis; 1999 May; 22(3):289-92. PubMed ID: 10384389
[No Abstract] [Full Text] [Related]
8. Comparison of urinary acylglycines and acylcarnitines as diagnostic markers of medium-chain acyl-CoA dehydrogenase deficiency.
Rinaldo P; O'Shea JJ; Goodman SI; Miller LV; Fennessey PV; Whelan DT; Hill RE; Tanaka K
J Inherit Metab Dis; 1989; 12 Suppl 2():325-8. PubMed ID: 2512435
[No Abstract] [Full Text] [Related]
9. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Gu XF
J Inherit Metab Dis; 2007 Aug; 30(4):507-14. PubMed ID: 17347912
[TBL] [Abstract][Full Text] [Related]
10. Analysis of abnormal urinary metabolites in the newborn period in medium-chain acyl-CoA dehydrogenase deficiency.
Bennett MJ; Coates PM; Hale DE; Millington DS; Pollitt RJ; Rinaldo P; Roe CR; Tanaka K
J Inherit Metab Dis; 1990; 13(5):707-15. PubMed ID: 2246856
[TBL] [Abstract][Full Text] [Related]
11. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
[TBL] [Abstract][Full Text] [Related]
12. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
Stanley CA
Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry].
Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Jin J; Gu XF
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2122-6. PubMed ID: 19080473
[TBL] [Abstract][Full Text] [Related]
14. Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine.
Rinaldo P; O'Shea JJ; Coates PM; Hale DE; Stanley CA; Tanaka K
N Engl J Med; 1988 Nov; 319(20):1308-13. PubMed ID: 3054550
[TBL] [Abstract][Full Text] [Related]
15. Population screening for medium-chain acyl-CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spots.
Bennett MJ; Ragni MC; Ostfeld RJ; Santer R; Schmidt-Sommerfeld E
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():72-7. PubMed ID: 8154855
[TBL] [Abstract][Full Text] [Related]
16. Acylglycine Analysis by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS).
Hobert JA; Liu A; Pasquali M
Curr Protoc Hum Genet; 2016 Oct; 91():17.25.1-17.25.12. PubMed ID: 27727436
[TBL] [Abstract][Full Text] [Related]
17. First case report of medium-chain acyl-coenzyme A dehydrogenase deficiency in China.
Liang C; Jiang M; Sheng H; Cai Y; Wu D; Yin X; Peng M; Liu L
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):681-4. PubMed ID: 25503862
[TBL] [Abstract][Full Text] [Related]
18. Ethylmalonic/adipic aciduria: effects of oral medium-chain triglycerides, carnitine, and glycine on urinary excretion of organic acids, acylcarnitines, and acylglycines.
Rinaldo P; Welch RD; Previs SF; Schmidt-Sommerfeld E; Gargus JJ; O'Shea JJ; Zinn AB
Pediatr Res; 1991 Sep; 30(3):216-21. PubMed ID: 1945558
[TBL] [Abstract][Full Text] [Related]
19. The inborn errors of mitochondrial fatty acid oxidation.
Vianey-Liaud C; Divry P; Gregersen N; Mathieu M
J Inherit Metab Dis; 1987; 10 Suppl 1():159-200. PubMed ID: 3119938
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of mitochondrial fatty acid oxidation defects.
Duran M; Bruinvis L; Ketting D; Dorland L
Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
